New Zealand markets close in 19 minutes

BIOR Oct 2022 3.500 call(CONTRA

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.02000.0000 (0.00%)
As of 12:50PM EDT. Market open.
Full screen
Previous close0.0200
Open0.0200
Bid0.0000
Ask0.0000
Strike3.50
Expiry date2022-10-21
Day's range0.0200 - 0.0200
Contract rangeN/A
Volume1
Open interestN/A
  • GlobeNewswire

    Biora Therapeutics Announces Presentation at the 2022 Parenteral Drug Association Universe of Pre-Filled Syringes and Injection Devices Conference

    SAN DIEGO, June 22, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, today announced the acceptance of an abstract presenting data on the autonomous triggering and injection efficiency of its systemic therapeutics delivery system by the Parenteral Drug Association (PDA) Universe of Pre-Filled Syringes and Injection Devices Conference. This meeting explores the latest technological advances in the drug delivery devices arena a

  • GlobeNewswire

    Biora Therapeutics Shares Presentation of Patient Data Establishing Correlation Between Drug Levels in Colon and Patient Outcomes in Ulcerative Colitis

    Oral Presentation Delivered at DDW 2022 Informs Clinical Study Design for Biora’s Targeted Therapeutics PlatformSAN DIEGO, May 31, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, today shared a presentation delivered during Digestive Disease Week® (DDW), May 21-24, 2022 in San Diego. DDW is the world’s premier meeting for physicians, researchers, and industry in the fields of gastroenterology, hepatology, endoscopy, and gast

  • GlobeNewswire

    Biora Therapeutics Shares Data Presented at Digestive Disease Week 2022

    Patient Data Suggests Multiple Additional Inflammatory Pathways, Supporting Potential Need for Combination Therapy for Ulcerative Colitis Patient Data Establishes Proof of Concept for Microbiome Sampling Capsule SAN DIEGO, May 25, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, today shared two posters that were presented during the Digestive Disease Week® (DDW), May 21-24, 2022 in San Diego. DDW is the world’s premier meeti